EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry

Aug.24
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.

Key Points

  • The European Ombudswoman formally opened Case 1036/2026/AML on August 18, 2026.
  • The inquiry examines how DG TRADE handles interactions with the tobacco industry, including their necessity and transparency.
  • The complainant alleges the contacts may conflict with EU obligations under the WHO Framework Convention on Tobacco Control, but no finding has yet been made.
  • The Ombudswoman has requested access to Commission documents concerning interactions with the tobacco industry.
  • In 2023, the Ombudsman found maladministration in the Commission’s handling of transparency and necessity assessments for meetings with tobacco lobbyists.

2Firsts

August 24, 2026

European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade (DG TRADE) handles interactions with the tobacco industry, IEU Monitoring reported on August 20, 2026.

The European Ombudsman’s Office said the case, numbered 1036/2026/AML, was formally opened on August 18. As a first step, the Ombudswoman has asked to inspect Commission documents concerning its interactions with the tobacco industry.

The inquiry remains ongoing and no finding has been made that DG TRADE engaged in maladministration or breached applicable obligations.

Complaint Questions Necessity and Transparency of Tobacco Contacts

The inquiry follows a complaint from a civil society organisation specialising in efforts to reduce tobacco consumption and exposure to tobacco smoke.

Based on information obtained through public access-to-documents requests, the organisation alleges that DG TRADE engaged in regular, unnecessary and non-transparent interactions with the tobacco industry.

The complainant also argues that such interactions risk undermining tobacco-control and public-health policies in countries outside the EU, particularly low- and middle-income countries.

Those claims are allegations made by the complainant and have not been established by the Ombudswoman.

The organisation further contends that the interactions may conflict with the EU’s obligations under the World Health Organization Framework Convention on Tobacco Control (FCTC).

Ombudswoman Requests Commission Documents

The Ombudswoman has begun the inquiry by seeking access to Commission documents concerning contacts with the tobacco industry.

The complaint was submitted on April 30, 2026, before progressing through analysis and inquiry procedures. The case was formally opened on August 18.

At this stage, the inquiry is examining how DG TRADE manages those interactions and whether its practices comply with applicable transparency and administrative requirements.

The opening of the case does not itself constitute a finding against DG TRADE.

Commission Previously Found at Fault Over Tobacco Lobbying Transparency

The latest inquiry follows an earlier Ombudsman investigation into the European Commission’s handling of tobacco industry contacts.

In 2023, the Ombudsman found maladministration in the Commission’s failure to ensure transparency consistently across its departments in relation to meetings with tobacco lobbyists.

The Ombudsman also found that the Commission had failed to ensure that all departments systematically assessed whether specific meetings with tobacco industry representatives were necessary.

The Commission subsequently carried out a risk assessment of departments’ exposure to tobacco industry lobbying and adopted measures intended to improve how such contacts are handled.

The new inquiry focuses specifically on DG TRADE and how the department currently manages interactions with tobacco industry representatives.

FCTC Obligations Form Part of the Inquiry

The case also raises questions about the EU’s obligations under the WHO Framework Convention on Tobacco Control.

Under the FCTC framework, parties are required to protect tobacco-control public-health policies from the commercial and other vested interests of the tobacco industry. Related implementation principles call for unnecessary interactions with the tobacco industry to be limited and for necessary contacts to be conducted transparently.

The complainant has relied on those obligations in challenging DG TRADE’s practices.

The Ombudswoman will now examine the relevant documentation and determine whether there was maladministration and whether further action by the European Commission is required.

Follow 2Firsts for the latest developments in global tobacco and nicotine regulation, policy and compliance.

Cover Image Source: IEU Monitoring


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's Ministry of Gender Equality and Family said on September 14 that it plans to designate unmanned e-cigarette stores as businesses where minors are prohibited from entering or working. Operators would be required to verify customers' ages and display notices restricting access by minors. The proposal is open for public comment through October 6. The move follows an April expansion of South Korea's statutory tobacco definition that brought products made with natural or synthetic nicotine under the Tobacco Business Act. Nicotine-free liquids and products using nicotine analogues such as 6-methylnicotine, however, remain an emerging regulatory issue.
Sep.21
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Holdings said the U.S. Food and Drug Administration notified the company on June 23, 2026, that 30 PACHA vape SKUs with submitted PMTAs had been tentatively identified for inclusion on a planned public-facing FDA webpage. Under enforcement guidance issued by FDA in May, the webpage is intended to identify certain unauthorized products for which the agency generally does not intend to prioritize enforcement of premarket authorization requirements. Charlie’s disclosed the development alongside second-quarter revenue of $3.8 million, up 116% year over year.
Aug.25
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14